14 Years of Excellence: South Korea’s Biggest Biologics Manufacturing Conference

Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well.

Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. Cygnus provides analytical tools and solutions delivering insights to improve bioprocess development for faster regulatory approval and better clinical outcomes.

--

DONGIL BIOTECH specializes and handles biotechnology -related products and is one of the leading companies in biopharmaceutical industry.

DONGIL BIOTECH handles biotechnology products in the market since 1998 when the enterprise was established. With a recognition of our value in biopharmaceutical industry, DONGIL BIOTECH has been constantly growing along with broad network based on a vision to provide the best quality product.

‍

Roquette is a family-owned global leader in plant-based ingredients, a pioneer of plant proteins and a leading provider of pharmaceutical excipients. Founded in 1933, the company currently operates in more than 100 countries.

Life and nature have been our sources of inspiration for decades. All our raw materials are of natural origin. From them, we offer pharmaceutical solutions that play a key role in medical treatments. We truly unlock the potential of nature to improve, cure and save lives.

Discover the Pharma Virtual Lab by Roquette

Follow Roquette Pharma Solutions Linked-in

‍

SimAbs specializes in continuous biologics manufacturing, offering CRO-CDMO services from an EU-GMP accredited facility. Our services include cell line , process development, analytical quality control, and regulatory support to ensure compliance and market readiness, with scalable production from R&D to commercial enabling EU market access. Partnered with ExSyn, experts in custom synthesis, we accelerate innovative biologics, biosimilars, and precision medicine solutions.

Thermo Fisher Scientific is a global scientific company achieving over $40 billion in revenue with the help of 125,000 employees worldwide. Guided by our mission to enable our customers to make the world healthier, cleaner, and safer, we support the acceleration of scientific research, solve complex analytical challenges, improve patient diagnostics and therapies, and enhance laboratory productivity. With these goals, we assist Korean companies leading the biopharmaceutical industry with top-notch technology and quality, providing End-to-End services throughout the drug development lifecycle, from solving complex analytical challenges to manufacturing scale-up.

Azenta Life Sciences is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

1st PhileKorea was founded in 2000 and is an ISO 9001 certified life sciences company. We supply over 20 global brands, including NEB, to the domestic market.

Our product range spans from basic molecular biology reagents to advanced research fields such as 3D cell culture and spatial biology. We are the official distributor of Oxford Nanopore, a leader in Long-Read sequencing technology, and NanoString, a pioneer in Spatial Biology in Korea.

With offices in Seoul and Daejeon, we provide not only research equipment and reagents but also experimental support services. We maintain close communication with domestic scientists and clinicians to offer customized solutions that directly contribute to their research.

We continually introduce products and information that reflect the latest trends in basic science and the biomedical field. Based on our technical expertise and reliable information, we strive to be a trusted partner. We are committed to collaboration with various institutions and companies both domestically and internationally, pursuing continuous growth through global partnerships

Gator Bio, Inc. is a pioneering life sciences company dedicated to providing analytical solutions that accelerate the development of therapeutics and diagnostics. Gator instruments and biosensors enable real-time analysis of biomolecular interactions, providing critical information on affinity, kinetics, concentration, epitope binning, and more. Gator Bio's analytical capabilities significantly enhance the characterization of drug candidates and viral vector analytics, delivering greater value in drug development and gene therapy applications. The company is headquartered in Palo Alto, California.

Our company provides essential consumables and equipment for cell&Gene therapy, from research to production. We specialize in products for stem cell, exosome, and vaccine development. Our focus is on delivering high-quality, specialized items to support your advanced therapy programs, ensuring efficient and safe manufacturing processes. We aim to accelerate your research and production of innovative cell-based products.

Evonik is one of the world leaders in the specialty chemicals industry. Active in more than 100 countries around the world, Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. We contribute small amounts of material that make a big difference. We provide the highest quality cell culture media ingredients for biologic drugs development & manufacturing, produce lipid nanoparticles essential in mRNA-based COVID-19 vaccines, make tires more fuel-efficient, and animal feeds healthier. As one of the key growth regions, Evonik has a strong production and R&D footprint in Asia Pacific. With over 5,000 employees at more than 50 production sites, the region contributed to €3.4 billion sales in 2021.

At Evonik, we offer high-quality cell culture solutions to pharmaceutical and biotech companies to help them boost cell culture performance in the manufacturing of therapeutic proteins like monoclonal antibodies, as well as in the production of viral vectors such as the adeno associated viral (AAV) vectors for gene therapy.

Commercially proven for reliable media performance across countless biological programs, our cQrex® portfolio features a range of peptides and keto acids designed to address key issues in mammalian cell culture.

Our latest offering, plant-derived cholesterol PhytoChol® Biopharma, which has been especially developed for use in animal-free cell culture media formulation, for example in chemically defined media which do not use fetal bovine serum (FBS). In addition, specialty carbohydrates like D-Mannose can be used as alternative energy sources and building blocks for intracellular protein glycosylation, enabling a higher flexibility in the production of therapeutic proteins.

All these cell culture ingredients are non-animal derived, readily available at commercial scale and can be customized to address specific project needs.

The ZETA Group is an end-to-end solution provider operating globally and specializing in the design, construction, automation, digitalization and qualification of customer-specific biopharmaceutical systems for aseptic process solutions.

The path of newly developed active substances in the lab into the preclinical phase and in early clinical GxP production, followed by scaling of the manufacturing process to industrial scale, through to market introduction in secure routine operation at the production facility is a complex and challenging process for the pharma and biotech industry. ZETA accompanies this entire active substance development and manufacturing process with comprehensive services and offers solutions for the construction, scaling and upgrade of production equipment.

ZETA provides support after commissioning of the process equipment through targeted ramp-up as well as service and maintenance along the entire product lifecycle. True to the principle of continuous improvement, ZETA guides customers during process and system optimization as well as operator training. ZETA’s aim is to achieve a 100% batch success rate.

As general planners, ZETA manages major, high-complexity pharma projects and specifically reduces interfaces—from the planning and construction of the process system through the cleanroom design up to the technical building infrastructure. This design-build approach accelerates the project execution time by up to 50% and leads to creation of value earlier in the customer’s capex projects. In doing so, ZETA provides an active contribution to the rapid market introduction of vital active ingredients and patients benefit from earlier availability of pharmaceuticals such as anti-cancer medications, insulin and vaccines.

In the field of digitization, ZETA’s fully integrated digital value chain—from engineering through qualification and operator management—has established the company as an innovation driver in the pharma and biotech industry. ZETA is also actively taking steps towards a more sustainable future for the entire industry: Holistic decarbonization strategies that reduce targeted emissions during the biopharmaceutical manufacturing process are integrated with sustainable energy sources for the power supply of the entire infrastructure and investment scenarios in renewable energy are evaluated using profitability calculations.

By leveraging FUJIFILM Group’s collective bio-related technologies, including FUJIFILM Wako Pure Chemical and FUJIFILM Biosciences, we continue to accelerate the growth and provide broad product portfolio in bio-medical through synergies and collaborations.

FUJIFILM Wako Pure Chemical (FFWK) is a world-wide supplier of high purity chemicals and reagents based in Japan.

FFWK has various raw materials including cell culture media for vaccine production, process liquid and QC/QA testing products, and provides services to support the process from the research stage to the commercial stage of pharmaceutical manufacturing.

Syngene International is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's 5000+ scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation. With a combination of dedicated research facilities for Baxter, and Bristol-Myers Squibb, as well as 2.2 million sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis, and Merck KGaA.

Bioconjugation Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugation field, including ADCs, oligonucleotide conjugates, protein and peptide conjugates, PEGylation, radioconjugates, conjugated vaccines, diagnostics, and more.

‍Bioconjugation Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation.